BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial.

Mischa de RidderLara C GerbrandyTheo M de ReijkeKarel A HinnenMaarten C C M Hulshof

Published in: The British journal of radiology (2020)

This novel liquid BioXmark® marker seems to be a very promising tool in daily-adaptive IGRT for bladder preserving chemoradiotherapy in muscle invasive bladder cancer.

Keyphrases

muscle invasive bladder cancer
locally advanced
ionic liquid
rectal cancer
early stage
study protocol
spinal cord injury
radiation therapy
phase iii
physical activity
squamous cell carcinoma
radiation induced
randomized controlled trial
urinary tract